Found: 13
Select item for more details and to access through your institution.
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
- Published in:
- Nature Medicine, 2005, v. 11, n. 11, p. 1170, doi. 10.1038/nm1319
- By:
- Publication type:
- Article
Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-Tropic HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 6, p. 803, doi. 10.1086/650697
- By:
- Publication type:
- Article
A Double-Blind, Placebo-Controlled Trial of Maraviroc in Treatment-Experienced Patients Infected with Non-R5 HIV-1.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 11, p. 1638, doi. 10.1086/598965
- By:
- Publication type:
- Article
A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 5, p. 508, doi. 10.1016/j.clpt.2005.07.010
- By:
- Publication type:
- Article
Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, p. 5, doi. 10.1111/j.1365-2125.2008.03130.x
- By:
- Publication type:
- Article
Population pharmacokinetic/ pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, p. 86, doi. 10.1111/j.1365-2125.2008.03140.x
- By:
- Publication type:
- Article
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 6, p. 996, doi. 10.1093/cid/ciac875
- By:
- Publication type:
- Article
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. 389, doi. 10.1093/cid/ciac804
- By:
- Publication type:
- Article
An exploratory survey measuring stigma and discrimination experienced by people living with HIV/AIDS in South Africa: the people living with HIV stigma index.
- Published in:
- BMC Public Health, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2458-14-80
- By:
- Publication type:
- Article
An exploratory survey measuring stigma and discrimination experienced by people living with HIV/AIDS in South Africa: the People Living with HIV Stigma Index.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Consent for Participation in the Bloemfontein Vitamin A Trial: How Informed and Voluntary?
- Published in:
- American Journal of Public Health, 2003, v. 93, n. 4, p. 582, doi. 10.2105/AJPH.93.4.582
- By:
- Publication type:
- Article
Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0204099
- By:
- Publication type:
- Article
Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection.
- Published in:
- 2015
- By:
- Publication type:
- Opinion